National Changhua University of Education Institutional Repository : Item 987654321/13235
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 6491/11663
造访人次 : 24515450      在线人数 : 76
RC Version 3.2 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 进阶搜寻


题名: Modeling of the in Vivo Kinetics of Antioxidants Delineates Suitable Parameters for Selecting Potential Antioxidant Adjuvants for Cancer Therapy
作者: Yang, Ming-Hua;Chuang, Chao-Ming;Hsieh, Chiu-Lan;Wang, Hui-Er;Chen, Kuan-Chou;Chiu, Wen-Ta;Shih, Chun-Ming;Peng, Robert Y.
贡献者: 生物技術研究所
关键词: Therapeutic behaviours;Quenching;Complementary therapy;Cancer
日期: 2010-03
上传时间: 2012-08-07T06:58:15Z
出版者: Informa Healthcare
摘要: To find in vivo behaviors of an antioxidant when used as an adjuvant cancer therapy, a more detailed integrated pharmacokinetic scheme is needed. Major reaction parameters associated with the sequential routes from ingestion to decay of an antioxidant were used in mathematical analysis, which included absorption rate coefficient k(a), quenching rate coefficient of the antioxidant k(q1) and tissue quenching rate coefficient k(r). The model was then treated with computer simulation using cited decay rate coefficients and some assumed parameters. When intestinal absorption rate coefficient k(a) becomes larger, retention time of antioxidant in plasma would be prolonged. moreover, k(a) had no effect on either quenching ability of antioxidants or tissue recovering capability. in quenching plasma ROS, the larger the quenching coefficient k(q1), the shorter peak- and the life-times would be for the secondary free radicals that are formed in primary quenching. Conclusively, it is suggestive to prescribe an antioxidant therapy with an appropriate values of k(a) and larger values of k(q1).
關聯: Pharamceutical Biology, 48(3) :306-317
显示于类别:[生物技術研究所] 期刊論文


档案 大小格式浏览次数
2020700210033.pdf25KbAdobe PDF422检视/开启



DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈